medigraphic.com
Órgano oficial de la Sociedad Mexicana de Cirugía Dermatológica y Oncológica, AC

2014, Number 1

<< Back Next >>

Dermatología Cosmética, Médica y Quirúrgica 2014; 12 (1)

Candida infections in a General Hospital: Clinico-epidemiological data and typification

Torres GE, Vásquez ME, Arenas R

Language: Spanish
References: 18
Page: 18-23
PDF size: 316.04 Kb.


ABSTRACT

Candidiasis is a group of primary or secondary mycoses caused by various species of opportunistic yeasts of the Candida genus, especially Candida albicans.
These are the results of a retrospective, cross-sectional epidemiological study implemented by the mycology section of a general hospital, in order to characterize the case mix of the January 2006-July 2012 period.


REFERENCES

  1. Arenas R. Micología Médica Ilustrada, 4ª ed., México, Mc GrawHill 2011; pp. 221-241.

  2. Aristimuño M, Arenas R. “Candidosis, experiencia en un servicio de dermatología”. Dermatología Rev Mex 1998; 42(5): 190-194.

  3. Benjamin DK Jr, Stoll BJ, Gantz MG, et al. “Neonatal candidiasis: epidemiology, risk factors, and clinical judgment”. Pediatrics 2010; 126(4): e865-873.

  4. Bonifaz A. Micología Médica Básica, 4ª ed., México, Mc GrawHill 2012; pp. 321-347.

  5. Guarda R, Gubelin W. Dermatología Esencial, 1ª reimpresión, Santiago de Chile, Editorial Mediterráneo 2012; pp. 71-72.

  6. Magill SS, Swoboda SM, Shields CE, et al. “The epidemiology of Candida colonization and invasive candidiasis in a surgical intensive care unit where fluconazole prophylaxis is utilized: follow-up to a randomized clinical trial”. Ann Surg 2009; 249(4): 657-665.

  7. Arendrup MC. “Epidemiology of invasive candidiasis”. Curr Opin Crit Care 2010; 16(5): 445-452.

  8. López Martínez R, Méndez Tovar LJ, Hernández Hernández F, Castañón Olivares R. Micología Médica, procedimientos para el diagnóstico de laboratorio, 2ª ed., México, Trillas 2006; pp. 99-107.

  9. Del Palacio A, Villar J, Alhambra A. “Epidemiology of invasive candidiasis in pediatric and adult populations”. Rev Iberoam Micol 2009; 26(1): 2-7.

  10. Manzano Gayosso P, Méndez Tovar LJ, Arenas R, et al. “Levaduras causantes de onicomicosis en cuatro centros dermatológicos mexicanos y su sensibilidad antifúngica a compuestos azólicos”. Rev Iberoam Micol 2011; 28(1): 32-35.

  11. Manzano-Gayosso P, Méndez-Tovar LJ, Hernández-Hernández F, López-Martínez R. “La resistencia a los antifúngicos, un problema emergente en México≠. Gac Med Mex 2008; 144(1): 23-26.

  12. Isa Isa R, Arenas R. Micosis superficiales, subcutáneas y pseudomicosis. México, Graphimedic 2009; pp. 43-46 .

  13. Pfaller MA, Diekema DJ. “Epidemiology of invasive candidiasis: a persistent public health problem”. Clin Microbiol Rev 2007; 20(1): 133-163.

  14. Fich F, Abarzúa-Araya A, Pérez M, Nauhm Y, León E. “Candida parapsilosis and Candida guilliermondii: Emerging pathogens in nail candidiasis”. Indian J Dermatol 2014; 59: 24-29.

  15. Singhi S, Deep A. “Invasive candidiasis in pediatric intensive care units”. Indian J Pediatr 2009; 76(10): 1033-1044.

  16. Concia E, Azzini AM, Conti M. “Epidemiology, incidence and risk factors for invasive candidiasis in high-risk patients”. Drugs 2009; suppl 1: 5-14.

  17. Hachem R, Hanna H, Kontoyiannis D, Jiang Y, Raad I. “The changing epidemiology of invasive candidiasis: Candida glabrata and Candida krusei as the leading causes of candidemia in hematologic malignancy”. Cancer 2008; 112(11): 2493-2499.

  18. Rodloff C, Koch D, Schaumann R. “Epidemiology and antifungal resistance in invasive candidiasis”. Eur J Med Res 2011; 16(4): 187-195.




2020     |     www.medigraphic.com